Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection - Quiz - MDSpire

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection

  • By

  • Xu Feng

  • Yupei Ao

  • Lili Wang

  • Kai Chen

  • Chengjia Tang

  • Chengcheng Huang

  • June 29, 2026

  • 0 min

Share

Original Source(s)

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection

  • by Xu Feng, Yupei Ao, Lili Wang, Kai Chen, Chengjia Tang, Chengcheng Huang

  • June 29, 2026

Related Content

Clinical evaluation of large language model recommendations in melanoma: comparison with multidisciplinary tumor board decisions in a real-world cohort

Evaluating glycolysis-associated biomarkers for radiotherapy sensitivity in head and neck squamous cancer

Chemical components of tattoo inks and their potential role in carcinogenesis and their side effects